Zoetis Inc. announced that it will expand its portfolio of equine horse care products, with the addition of Pro-Stride® APS, Restigen® PRP and CenTrate® BMA, a range of devices designed to help address injuries common in horses that may cause lameness. These stall-side devices offer the opportunity to harness a horse's own natural healing mechanisms to manage joint and soft tissue ailments. A major benefit of using these devices is the ability for easy stall-side processing of the horses' blood or bone marrow, allowing for immediate use within 15 to 20 minutes of centrifugation; eliminating the need for incubation or off-site preparation. Pro-Stride APS, Restigen PRP and CenTrate BMA complement the ever-expanding Zoetis family of horse care products. Zoetis will exclusively sell these products to veterinarians through key distributor partners.